Pharming Group (CHIX:PHARMA) Beginning Cash Position : €50.8 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Pharming Group Beginning Cash Position?

Pharming Group's Beginning Cash Position for the quarter that ended in Mar. 2025 was €50.8 Mil.

Pharming Group's quarterly Beginning Cash Position increased from Sep. 2024 (€42.5 Mil) to Dec. 2024 (€57.9 Mil) but then declined from Dec. 2024 (€57.9 Mil) to Mar. 2025 (€50.8 Mil).

Pharming Group's annual Beginning Cash Position increased from Dec. 2022 (€181.2 Mil) to Dec. 2023 (€190.1 Mil) but then declined from Dec. 2023 (€190.1 Mil) to Dec. 2024 (€59.0 Mil).

Pharming Group Beginning Cash Position Historical Data

The historical data trend for Pharming Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Beginning Cash Position Chart

Pharming Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

61.11

181.57

181.18

190.13

58.96

Pharming Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															56.80	48.21	42.47	57.93	50.82

Pharming Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Pharming Group Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Pharming Group's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (CHIX:PHARMa) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

PHAR:USA PHGUF:USA PHARM:Netherlands 0QCO:UK PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Pharming Group Headlines

No Headlines